Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Trypsinogen mutations in pancreatic disorders.

Louis J Vitone¹, William Greenhalf, Nathan R Howes

¹Division of Surgery and Oncology, The University of Liverpool, 5th Floor UCD Building, Daulby Street, Liverpool, L69 3GA, United Kingdom.

Endocrinology and Metabolism Clinics of North America

|April 25, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The benefit of deep genomic testing for asymptomatic high-risk individuals undergoing surveillance for pancreatic adenocarcinoma: European registry for hereditary pancreatic diseases (EUROPAC-PLUS).

Neoplasia (New York, N.Y.)·2026

Same author

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

The Journal of antimicrobial chemotherapy·2026

Same author

Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.

Lancet (London, England)·2026

Same author

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Same author

A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Same author

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Clinical pharmacology and therapeutics·2026

Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026

Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026

Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026

Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026

Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026

Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026

See all related articles

Hereditary pancreatitis is linked to PRSS1 mutations, particularly N29I and R122H. Understanding these genetic variations is key to explaining early-onset pancreatitis and its diverse origins.

Area of Science:

Genetics
Gastroenterology
Molecular Biology

Background:

Hereditary pancreatitis is a genetic disorder characterized by recurrent episodes of pancreatic inflammation.
Mutations in the PRSS1 gene are the most common cause of hereditary pancreatitis.
While numerous PRSS1 mutations exist, only a subset are clinically significant, necessitating further investigation into their specific roles.

Purpose of the Study:

To investigate the clinical relevance and origins of common PRSS1 mutations in hereditary pancreatitis.
To elucidate the underlying mechanisms by which PRSS1 mutations lead to early-onset pancreatitis.
To explore the population genetics and evolutionary history of prevalent PRSS1 mutations.

Main Methods:

Literature review of PRSS1 mutations associated with hereditary pancreatitis.

Related Experiment Videos

Analysis of mutation frequencies across diverse racial populations.

Review of proposed mechanisms, including gene conversion, for mutation origin.

Main Results:

The N29I (exon 2) and R122H (exon 3) PRSS1 mutations are the most frequent and clinically relevant, observed across diverse populations.
These mutations are associated with early-onset pancreatitis, though the precise pathogenic mechanisms remain incompletely understood.
The widespread occurrence of these mutations suggests multiple independent origins, potentially explained by gene conversion events.

Conclusions:

The N29I and R122H PRSS1 mutations are significant drivers of hereditary pancreatitis with early onset.
Gene conversion may explain the recurrent emergence of these major mutations, accounting for multiple founders.
Further research into mutation mechanisms and clinical correlations is crucial for understanding and managing hereditary pancreatitis.